HomeYAG2 • FRA
add
Atossa Therapeutics Inc
Previous close
€0.72
Day range
€0.71 - €0.71
Year range
€0.52 - €1.50
Market cap
107.42M USD
Avg Volume
3.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.41M | 6.22% |
Net income | -6.72M | -14.29% |
Net profit margin | — | — |
Earnings per share | -0.05 | 0.00% |
EBITDA | -7.41M | -6.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 65.12M | -22.44% |
Total assets | 70.75M | -22.33% |
Total liabilities | 5.42M | 1.82% |
Total equity | 65.32M | — |
Shares outstanding | 129.17M | — |
Price to book | 1.40 | — |
Return on assets | -25.18% | — |
Return on capital | -27.10% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -6.72M | -14.29% |
Cash from operations | -5.96M | -26.84% |
Cash from investing | -9.00K | -50.00% |
Cash from financing | — | — |
Net change in cash | -5.97M | -32.62% |
Free cash flow | -3.87M | -21.38% |
About
Founded
2008
Headquarters
Website
Employees
15
